Public-registry trials using ATH434 that Eichor's radar has found — 2 trials. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| A Biomarker Study of ATH434 in Participants With MSA | Alterity Therapeutics | Multiple System Atrophy | PHASE2 | 1 |
| Open-Label Access to ATH434 for Patients Who Completed Study ATH434-201 in France | Alterity Therapeutics | Multiple System Atrophy | PHASE2 | 4 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →